Previous Close | 0.0350 |
Open | 0.0350 |
Bid | 0.0300 x N/A |
Ask | 0.0350 x N/A |
Day's Range | 0.0350 - 0.0350 |
52 Week Range | 0.0200 - 0.1500 |
Volume | |
Avg. Volume | 7,148 |
Market Cap | 1.667M |
Beta (5Y Monthly) | -1.08 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
CareSpan Health, Inc. (TSXV: CSPN) ("Company" or "CareSpan"), announces that the TSX Venture Exchange (the "Exchange") has suspended trading in the Company's securities as a result of a Cease Trade Order ("CTO") issued by the British Columbia Securities Commission due to the Company's failure to file its annual financial statements for the year ended December 31, 2023, including the related management discussion and analysis, and CEO and CFO certifications (collectively, the "Annual Financial Fi
CareSpan Health, Inc. (TSXV: CSPN) ("CareSpan" or the "Company") is pleased to announce that on February 29, 2024 it closed a transaction for aggregate gross proceeds of approximately USD$1,000,000 involving the: (i) sale of the Company's fifteen percent (15%) minority equity interest in CareSpan Asia Inc. ("CareSpan Asia"), a Philippines based corporation and (ii) exchange of certain software rights (as detailed below) between the Company and CareSpan Asia (the "Transaction"). The net proceeds
CareSpan Health, Inc. (TSXV: CSPN) ("Company" or "CareSpan"), announces that it has issued 333,738 common shares in the capital of the Company ("Common Shares") pursuant to a consulting agreement dated June 1, 2022 (the "Consulting Agreement") between the Company and Darrell Messersmith, the Chief Operating Officer of the Company (the "Consultant").